Autoinflammatory diseases: clinical and genetic advances

Area of Science:

• Genetics and Molecular Biology
• Immunology
• Rheumatology

Background:

• Autoinflammatory diseases are inherited disorders characterized by unprovoked inflammation.
• Seven key autoinflammatory diseases are reviewed: familial Mediterranean fever, TNF receptor-associated periodic syndrome, hyperimmunoglobulinemia D with periodic fever syndrome, pyogenic arthritis, pyoderma gangrenosum, and acne syndrome, and the three cryopyrinopathies.

Purpose of the Study:

• To review recent advances in the genetics, molecular biology, clinical manifestations, and therapy of seven inherited autoinflammatory diseases.
• To elucidate the shared pathogenetic mechanisms and therapeutic strategies for these conditions.

Main Methods:

• Literature review of recent scientific publications.
• Analysis of genetic and molecular findings.
• Evaluation of clinical presentations and therapeutic outcomes.

Main Results:

• Identification of susceptibility genes has expanded the understanding of autoinflammatory disease spectrum and molecular basis.
• Cryopyrinopathies are linked to mutations in the CIAS1 gene, encoding cryopyrin, forming a disease continuum.
• Activation of the interleukin-1beta pathway is a common pathogenetic mechanism across these diseases.
• Anakinra, an IL-1 receptor antagonist, shows promise in treating cryopyrinopathies and other autoinflammatory conditions.

Conclusions:

• Advances in genetics and molecular biology have significantly improved understanding of autoinflammatory disease pathogenesis.
• Shared inflammatory pathways, particularly involving IL-1beta, unify these diverse genetic disorders.
• Targeted therapies like anakinra offer new hope for managing autoinflammatory diseases, improving both cutaneous and systemic inflammation.